155 related articles for article (PubMed ID: 38275002)
1. Robustness of magnetic resonance imaging and positron emission tomography radiomic features in prostate cancer: Impact on recurrence prediction after radiation therapy.
Dutta A; Chan J; Haworth A; Dubowitz DJ; Kneebone A; Reynolds HM
Phys Imaging Radiat Oncol; 2024 Jan; 29():100530. PubMed ID: 38275002
[TBL] [Abstract][Full Text] [Related]
2. Physics-Informed Discretization for Reproducible and Robust Radiomic Feature Extraction Using Quantitative MRI.
Zhao W; Hu Z; Kazerooni AF; Körzdörfer G; Nittka M; Davatzikos C; Viswanath SE; Wang X; Badve C; Ma D
Invest Radiol; 2024 May; 59(5):359-371. PubMed ID: 37812483
[TBL] [Abstract][Full Text] [Related]
3. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
[TBL] [Abstract][Full Text] [Related]
4. Role of radiomic analysis of [
Marturano F; Guglielmo P; Bettinelli A; Zattoni F; Novara G; Zorz A; Sepulcri M; Gregianin M; Paiusco M; Evangelista L
Eur Radiol; 2023 Oct; 33(10):7199-7208. PubMed ID: 37079030
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
[TBL] [Abstract][Full Text] [Related]
6. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
[TBL] [Abstract][Full Text] [Related]
7. Imaging-Based Individualized Response Prediction Of Carbon Ion Radiotherapy For Prostate Cancer Patients.
Wu S; Jiao Y; Zhang Y; Ren X; Li P; Yu Q; Zhang Q; Wang Q; Fu S
Cancer Manag Res; 2019; 11():9121-9131. PubMed ID: 31695500
[TBL] [Abstract][Full Text] [Related]
8. A Critical Analysis of the Robustness of Radiomics to Variations in Segmentation Methods in
Pasini G; Russo G; Mantarro C; Bini F; Richiusa S; Morgante L; Comelli A; Russo GI; Sabini MG; Cosentino S; Marinozzi F; Ippolito M; Stefano A
Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132224
[TBL] [Abstract][Full Text] [Related]
9. Reliability of tumor segmentation in glioblastoma: Impact on the robustness of MRI-radiomic features.
Tixier F; Um H; Young RJ; Veeraraghavan H
Med Phys; 2019 Aug; 46(8):3582-3591. PubMed ID: 31131906
[TBL] [Abstract][Full Text] [Related]
10. Improving radiomic model reliability using robust features from perturbations for head-and-neck carcinoma.
Teng X; Zhang J; Ma Z; Zhang Y; Lam S; Li W; Xiao H; Li T; Li B; Zhou T; Ren G; Lee FK; Au KH; Lee VH; Chang ATY; Cai J
Front Oncol; 2022; 12():974467. PubMed ID: 36313629
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance radiomic feature performance in pulmonary nodule classification and impact of segmentation variability on radiomics.
Koo CW; Kline TL; Yoon JH; Vercnocke AJ; Johnson MP; Suman G; Lu A; Larson NB
Br J Radiol; 2022 Dec; 95(1140):20220230. PubMed ID: 36367095
[TBL] [Abstract][Full Text] [Related]
12. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility and non-redundancy of radiomic features extracted from arterial phase CT scans in hepatocellular carcinoma patients: impact of tumor segmentation variability.
Qiu Q; Duan J; Duan Z; Meng X; Ma C; Zhu J; Lu J; Liu T; Yin Y
Quant Imaging Med Surg; 2019 Mar; 9(3):453-464. PubMed ID: 31032192
[TBL] [Abstract][Full Text] [Related]
14. Robustness of radiomics to variations in segmentation methods in multimodal brain MRI.
Poirot MG; Caan MWA; Ruhe HG; Bjørnerud A; Groote I; Reneman L; Marquering HA
Sci Rep; 2022 Oct; 12(1):16712. PubMed ID: 36202934
[TBL] [Abstract][Full Text] [Related]
15. MRI-based radiomic features for identifying recurrent prostate cancer after proton radiation therapy.
Gumus KZ; Contreras SS; Al-Toubat M; Harmon I; Hernandez M; Ozdemir S; Kumar S; Yuruk N; Mete M; Balaji KC; Bandyk M; Gopireddy DR
J Appl Clin Med Phys; 2024 Feb; 25(3):e14293. PubMed ID: 38409947
[TBL] [Abstract][Full Text] [Related]
16. Stability and Reproducibility of Radiomic Features Based on Various Segmentation Techniques on Cervical Cancer DWI-MRI.
Ramli Z; Karim MKA; Effendy N; Abd Rahman MA; Kechik MMA; Ibahim MJ; Haniff NSM
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553132
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging radiomic feature analysis of radiation-induced femoral head changes in prostate cancer radiotherapy.
Abdollahi H; Mahdavi SR; Shiri I; Mofid B; Bakhshandeh M; Rahmani K
J Cancer Res Ther; 2019 Mar; 15(Supplement):S11-S19. PubMed ID: 30900614
[TBL] [Abstract][Full Text] [Related]
18. Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy.
Chan TH; Haworth A; Wang A; Osanlouy M; Williams S; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Reynolds HM
EJNMMI Res; 2023 Apr; 13(1):34. PubMed ID: 37099047
[TBL] [Abstract][Full Text] [Related]
19. Robustness of Radiomic Features: Two-Dimensional versus Three-Dimensional MRI-Based Feature Reproducibility in Lipomatous Soft-Tissue Tumors.
Sudjai N; Siriwanarangsun P; Lektrakul N; Saiviroonporn P; Maungsomboon S; Phimolsarnti R; Asavamongkolkul A; Chandhanayingyong C
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673068
[TBL] [Abstract][Full Text] [Related]
20. An Integrated Radiomics Model Incorporating Diffusion-Weighted Imaging and
Zhang L; Yao R; Gao J; Tan D; Yang X; Wen M; Wang J; Xie X; Liao R; Tang Y; Chen S; Li Y
Front Oncol; 2021; 11():732704. PubMed ID: 34527594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
